Nov 18 (Reuters) - Acarix AB ACARIX.ST :
* POSITIVE RESULTS FROM ACARIX STUDY PRESENTED AT ISPOR, A LEADING HEALTH ECONOMICS
CONFERENCE
* ACARIX AB - IN CLINICAL TRIALS, ULTRA-SENSITIVE PHONOCARDIOGRAPHY HAS PROVEN TO BE A
CLINICALLY
RELEVANT DIAGNOSTIC MEASUREMENT
* ACARIX AB - STUDY COMPARED TWO PATIENT SETS, 1030 PATIENTS FROM GERMANY AND AUSTRIA AND
1501
FROM DANNICAD-1 TRIAL IN DENMARK
* ACARIX AB - CONCLUSION REACHED IS THAT "IN CLINICAL TRIALS, ULTRA-SENSITIVE
PHONOCARDIOGRAPHY
HAS PROVEN TO BE A CLINICALLY RELEVANT DIAGNOSTIC MEASUREMENT
Source text for Eikon: ID:nGNE33MWf7
Further company coverage: ACARIX.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))